https://www.selleckchem.com/pr....oducts/SB-525334.htm
Before PSM, the PPIs group had a higher rate of mortality than the control group [RR = 1.065; 95% confidence ratio (CI) 1.045-1.086; p = 0.001]. After PSM, there was no significant difference in mortality (RR = 1.009; 95% CI, 0.999-1.019; p = 0.554) or total hospital stay (p = 0.856), although the PPIs group had a lower occurrence of pancreatic pseudocyst (RR = 0.416; 95% CI 0.221-0.780; p = 0.005). Conclusion This study showed that PPIs therapy was not associated with reduced mortality or total hospital stay, but was associated with
Like
Comment
Share
